B&G Foods (BGS) Competitors

Medifast (NYSE:MED) and B&G Foods (NYSE:BGS) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, media sentiment and valuation.

Is MED or BGS more profitable?

Medifast has a net margin of 0.76% compared to B&G Foods' net margin of -12.02%. B&G Foods' return on equity of 7.16% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medifast	0.76%	2.00%	1.50%
B&G Foods	-12.02%	7.16%	1.34%

Do analysts prefer MED or BGS?

Medifast presently has a consensus price target of $16.50, suggesting a potential upside of 17.61%. B&G Foods has a consensus price target of $6.10, suggesting a potential upside of 36.62%. Given B&G Foods' higher probable upside, analysts plainly believe B&G Foods is more favorable than Medifast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
B&G Foods	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Which has more risk and volatility, MED or BGS?

Medifast has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, B&G Foods has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.

Does the media favor MED or BGS?

In the previous week, B&G Foods had 4 more articles in the media than Medifast. MarketBeat recorded 10 mentions for B&G Foods and 6 mentions for Medifast. B&G Foods' average media sentiment score of 1.22 beat Medifast's score of -0.44 indicating that B&G Foods is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medifast	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
B&G Foods	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of MED or BGS?

95.5% of Medifast shares are owned by institutional investors. Comparatively, 66.2% of B&G Foods shares are owned by institutional investors. 2.9% of Medifast shares are owned by company insiders. Comparatively, 3.2% of B&G Foods shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has preferable earnings and valuation, MED or BGS?

Medifast has higher earnings, but lower revenue than B&G Foods. B&G Foods is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$602.46M	0.26	$2.09M	$0.32	43.84
B&G Foods	$1.93B	0.18	-$251.25M	-$2.83	-1.58

Summary

Medifast beats B&G Foods on 9 of the 15 factors compared between the two stocks.